Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma

NCT02973217 is registered in ClinicalTrials.gov with Clinical Laserthermia Systems AB as lead sponsor.

NCT NCT02973217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma
Lead sponsor
Clinical Laserthermia Systems AB
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
July 22, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms pancreatic